This article seeks to review newer ART agents, as well as those in later stages of drug development, for the treatment of HIV-1 infection.
Jeremy D. Young, MD, MPH
Advertisement
Articles by Jeremy D. Young, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Invivyd doses first participants in phase 3 COVID-19 trial of VYD2311
2
ASM Initiative Aims to Advance Phage Therapy for Drug-Resistant Infections
3
The HIV Testing Gap and What Clinicians Can Do About It
4
When Fever in Infants is Invasive Bacterial Infection
5